Guru Ownership Trend
Guru Analysis for Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.41 M.
Top institutional holders include Chuck Royce and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.35 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Chuck Royce reduced exposure by 3.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Cytek Biosciences, Inc. (CTKB)
Major holders include Chuck Royce ($7.18 M), Cliff Asness ($3.99 M), Renaissance Technologies (RenTech) ($2.96 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 3.55 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.35 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CTKB. The total reported sell value was $796,755.93.
Yes, 1 managers opened new positions in CTKB, and 2 increased their existing holdings. The total reported buy value was $2.15 M.